Cov-hep study: heparin in standard anticoagulation based on citrate for continuous veno-venous hemodialysis in patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial

OBJECTIVES: The primary objective is to test if heparin added to a standard regional anticoagulation protocol based on citrate is able to reduce dialysis circuit losses by clotting without increasing the risk of thrombocytopenia or bleeding, in patients with COVID-19 with acute kidney injury requiri...

Descripción completa

Detalles Bibliográficos
Autores principales: Lins, Paulo Ricardo Gessolo, de Albuquerque, Claudia Coimbra César, Assis, Camila Fernandes, Rodrigues, Bruna Cristine Duarte, e Siqueira Campos, Beatriz Pinto, de Oliveira Valle, Eduardo, Cabrera, Carla Paulina Sandoval, de Oliveira Gois, Jeison, Segura, Gabriela Cardoso, Strufaldi, Fernando Louzada, Mainardes, Lorena Catelan, Ribeiro, Rayra Gomes, Via Reque Cortes, Daniela Del Pilar, Lutf, Luciana Gil, de Oliveira, Márcia Fernanda Arantes, Sales, Gabriel Teixeira Montezuma, Smolentzov, Igor, Reichert, Bernardo Vergara, Andrade, Lucia, Seabra, Victor Faria, Rodrigues, Camila Eleuterio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656196/
https://www.ncbi.nlm.nih.gov/pubmed/33176886
http://dx.doi.org/10.1186/s13063-020-04814-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656196/
https://www.ncbi.nlm.nih.gov/pubmed/33176886
http://dx.doi.org/10.1186/s13063-020-04814-0

Ejemplares similares